SCHEMBL18824672

SCHEMBL18824672

CC(C)c1nc2ccc(-c3ccc(OCCCN(C)C)cc3)cc2c2[nH]c(=O)n(C)c12

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 7/20 0.57
▸ ATR Q13535 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ ADORA2B P29275 1/20 0.43
▸ ADORA1 P30542 1/20 0.43
▸ LSS P48449 1/20 0.42
▸ CHEK2 O96017 1/20 0.42
▸ PDE3B Q13370 3/20 0.41
▸ PDE3A Q14432 3/20 0.41
▸ P2RY12 Q9H244 1/20 0.41
▸ TLR7 Q9NYK1 2/20 0.41
▸ PDE2A O00408 2/20 0.40
▸ TNKS O95271 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ PIK3CA P42336 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18824690 0.96 ATM (0.52) ATMATRADORA3ADORA2AADORA2B
SCHEMBL18844674 0.81 ATM (0.64) ATMATRPDE3BPDE3AP2RY12
SCHEMBL18824834 0.79 ATM (0.46) ATMATRADORA3ADORA2AADORA2B
SCHEMBL18641851 0.79 ATM (0.62) ATMPIK3CA
SCHEMBL18824924 0.78 ATM (0.59) ATMATRPDE3BPDE3AP2RY12
SCHEMBL18824692 0.77 ATM (0.48) ATMATRADORA3ADORA2AADORA2B
SCHEMBL18641733 0.77 ATM (0.42) ATMATRPIK3CA
SCHEMBL18641856 0.75 ATM (0.61) ATMATRPIK3CA
SCHEMBL18824583 0.75 ATM (0.54) ATMATRADORA3ADORA2AADORA2B
SCHEMBL18641743 0.73 TYMS (0.40) ATMPDE3BPDE3APDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3371183-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2018-09-12 — — EP disclosed
WO-2017076895-A1 IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2017-05-11 — — WO disclosed
Send feedback